Market Overview: Introduced in 1990, Adagen serves as the pioneer alternative treatment for Severe Combined Immunodeficiency (SCID), offering a substitute to bone marrow transplants. SCID, an inherited primary immunodeficiency disease, manifests as an extreme immune deficiency, resulting in a weakened immune system incapable of combatting even mild infections. ADA-SCID, constituting 15-20% of all SCID cases, is the second most prevalent form, characterized by genetic defects affecting T cells, B cells, and natural killer cells. Commonly known as Bubble Boy Syndrome, ADA-SCID patients without treatment must live in controlled environments, resembling a bubble, to avoid exposure to microorganisms.

Get a sample copy of the Adagen Market report: https://www.reportsanddata.com/download-free-sample/3653

Statistics indicate ADA-SCID's rarity, with the U.S. recording one case per 100,000 to 200,000 live births. In the UK, between 2008 and 2009, 20 children per year were affected, reflecting an incidence of approximately 1 in 35,000 to 660,000 live births. A 2015 global study identified 2,910 ADA-SCID cases in the U.S., Germany, France, Italy, Spain, the U.K., and Japan.

Adagen Market Dynamics: Anticipated growth in the Adagen market stems from the scarcity of alternatives for ADA-SCID treatment. While PEGylated bovine adenosine deaminase enzyme (ADA) injection and Strimvelis exist, Adagen, developed by Leadiant Biosciences, remains a primary choice. Strimvelis, a gene therapy approved in 2016, has limited uptake and is currently available only in Italy. Plans for a manufacturing plant and expanded distribution may influence the Adagen market's growth.

In 2015, Adagen's market size was USD 7 million, reflecting a decline due to decreased sales and limited alternatives. A significant unmet demand for accurate ADA-SCID diagnosis persists, often leading to delayed treatment. Research activity in this rare disease space remains relatively limited.

Adagen Market: Regional Outlook Regionally, North America and Europe are poised for substantial market expansion due to advancements in healthcare, increased awareness of health conditions, and superior facilities. Early ADA-SCID diagnosis is crucial, and the developed healthcare sectors in these regions contribute to Adagen's extensive market presence.

Adagen Market: Competitive Landscape Leading manufacturers in the Adagen market, including Leadiant Biosciences, Sigma-Tau PharmaSource, Inc., are adopting strategies and collaborations to gain a competitive edge. The report provides a comprehensive analysis of manufacturers' market footprints, considering global revenue, global presence, and sales during the forecast period (2017-2027).

Impact of COVID-19 on Adagen Market: Despite the COVID-19 pandemic's impact on the pharmaceutical industry, the Adagen market retains an optimistic outlook. As an essential drug for ADA-SCID patients, the demand for Adagen is expected to remain unaffected. Although healthcare systems globally face challenges, it is anticipated that once an effective vaccine is launched, the Adagen market will witness positive growth.

Regional Analysis: The report includes an in-depth analysis of North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa, considering various factors influencing regional growth.

Report Highlights:

  • Detailed overview of the parent market
  • Evolving Adagen market dynamics
  • In-depth segmentation of the Adagen market
  • Historical, present, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Key players' strategies and products
  • Potential and sub-segments with promising growth
  • Neutral perspective on Adagen market performance

Adagen Market Segmentation: The report segments the Adagen market based on product type (Pre-filled, Vial) and application (Hospital, Specialty Clinic, Recovery Center) for the period 2017-2027, providing insights into revenue growth globally, regionally, and by country.

Explore Trending Reports:

Industrial Coatings Market-https://www.reportsanddata.com/report-detail/industrial-coatings-market

Trivalent Chromium Finishing Market-https://www.reportsanddata.com/report-detail/trivalent-chromium-finishing-market

Cosmetic Chemicals Market-https://www.reportsanddata.com/report-detail/cosmetic-chemicals-market

Coating Additives Market-https://www.reportsanddata.com/report-detail/coating-additives-market

Pigment Dispersion Market-https://www.reportsanddata.com/report-detail/pigment-dispersion-market

Request a customization of the report: https://www.reportsanddata.com/request-customization-form/3653

Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.

About Reports and Data    

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report